Danièle Debruyne

2.1k total citations
81 papers, 1.6k citations indexed

About

Danièle Debruyne is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Danièle Debruyne has authored 81 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 21 papers in Molecular Biology and 19 papers in Cellular and Molecular Neuroscience. Recurrent topics in Danièle Debruyne's work include Forensic Toxicology and Drug Analysis (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Neuroscience and Neuropharmacology Research (9 papers). Danièle Debruyne is often cited by papers focused on Forensic Toxicology and Drug Analysis (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Neuroscience and Neuropharmacology Research (9 papers). Danièle Debruyne collaborates with scholars based in France, United States and Canada. Danièle Debruyne's co-authors include Jean‐Philippe Ryckelynck, Reynald Le Boisselier, Maryline Moulin, Louisa Barré, Véronique Lelong‐Boulouard, Bruno Hurault de Ligny, Antoine Coquerel, Gilles Defer, Géraldine Poisnel and R. Camsonne and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Journal of Chromatography A.

In The Last Decade

Danièle Debruyne

79 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danièle Debruyne France 20 429 326 298 287 259 81 1.6k
Kara L. Lynch United States 30 319 0.7× 674 2.1× 838 2.8× 226 0.8× 423 1.6× 119 2.9k
Hugo Kupferschmidt Switzerland 23 293 0.7× 337 1.0× 242 0.8× 132 0.5× 70 0.3× 89 1.8k
Nicola Montanaro Italy 27 365 0.9× 601 1.8× 223 0.7× 440 1.5× 78 0.3× 97 2.2k
Raffaele Giorgetti Italy 24 355 0.8× 295 0.9× 839 2.8× 288 1.0× 75 0.3× 74 1.7k
Gordon McKay Canada 17 486 1.1× 436 1.3× 126 0.4× 141 0.5× 127 0.5× 23 2.1k
Andrew A. Monte United States 24 1.0k 2.4× 224 0.7× 347 1.2× 118 0.4× 73 0.3× 104 2.1k
Albert D. Fraser Canada 24 254 0.6× 170 0.5× 311 1.0× 179 0.6× 69 0.3× 83 1.8k
S. Hill United Kingdom 17 490 1.1× 151 0.5× 652 2.2× 325 1.1× 71 0.3× 40 1.4k
S. Casey Laizure United States 21 509 1.2× 281 0.9× 116 0.4× 105 0.4× 112 0.4× 53 1.4k
Heather D. Langtry New Zealand 24 358 0.8× 391 1.2× 54 0.2× 148 0.5× 178 0.7× 31 2.2k

Countries citing papers authored by Danièle Debruyne

Since Specialization
Citations

This map shows the geographic impact of Danièle Debruyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danièle Debruyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danièle Debruyne more than expected).

Fields of papers citing papers by Danièle Debruyne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danièle Debruyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danièle Debruyne. The network helps show where Danièle Debruyne may publish in the future.

Co-authorship network of co-authors of Danièle Debruyne

This figure shows the co-authorship network connecting the top 25 collaborators of Danièle Debruyne. A scholar is included among the top collaborators of Danièle Debruyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danièle Debruyne. Danièle Debruyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peyro‐Saint‐Paul, Laure, Maxence Ficheux, Danièle Debruyne, et al.. (2018). Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study. Peritoneal Dialysis International. 38(6). 463–466. 8 indexed citations
2.
Spadari, Michel, Anne Batisse, Marylène Guerlais, et al.. (2016). Les aspects actuels de l’usage de l’ecstasy/MDMA en France. Therapies. 71(6). 553–562. 9 indexed citations
3.
Debruyne, Danièle, et al.. (2014). Emerging drugs of abuse: current perspectives on substituted cathinones. PubMed. 5. 37–37. 88 indexed citations
4.
Eiden, Céline, et al.. (2013). Toxicity and death following recreational use of 2-pyrrolidino valerophenone. Clinical Toxicology. 51(9). 899–903. 42 indexed citations
5.
Dhilly, Martine, et al.. (2012). Radiolabelling of 1,4-disubstituted 3-[18F]fluoropiperidines and its application to new radiotracers for NR2B NMDA receptor visualization. Organic & Biomolecular Chemistry. 10(42). 8493–8493. 9 indexed citations
6.
7.
Parienti, Jean Jacques, Claire Daurel, Danièle Debruyne, et al.. (2011). An information campaign on aminoglycosides use during septic shock failed to improve the quality of care. Annales Françaises d Anesthésie et de Réanimation. 31(1). e1–e5. 2 indexed citations
8.
Lin, Lin, Reynald Le Boisselier, Véronique Lelong‐Boulouard, et al.. (2009). Comparaison des données analytiques et anamnestiques des consommations de drogues et psychotropes chez des usagers d’opiacés en traitement de substitution. Étude de faisabilité. Therapies. 64(4). 269–277. 5 indexed citations
9.
Prémaud, Aurélie, Annick Rousseau, Yannick Le Meur, et al.. (2009). Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: Pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipients. Pharmacological Research. 61(2). 167–174. 13 indexed citations
10.
Boisselier, Reynald Le, et al.. (2008). Le syndrome de la poche à urine violette : à propos d’un cas avec identification des substances colorantes. Journal de Pharmacie Clinique. 27(2). 80–84.
11.
Lelong‐Boulouard, Véronique, et al.. (2007). Cyclosporine Monitoring in Peripheral Blood Mononuclear Cells: Feasibility and Interest. A Prospective Study on 20 Renal Transplant Recipients. Transplantation Proceedings. 39(10). 3109–3110. 11 indexed citations
12.
Poisnel, Géraldine, Thomas Quentin, Louisa Barré, Antoine Coquerel, & Danièle Debruyne. (2006). Competitive displacement binding assay on rat brain sections and using a β-imager: Application to μ-opioid ligands. Journal of Neuroscience Methods. 154(1-2). 60–67. 18 indexed citations
13.
Haggan, Waël El, Maxence Ficheux, Danièle Debruyne, et al.. (2005). Pharmacokinetics of Mycophenolic Acid in Kidney Transplant Patients Receiving Sirolimus Versus Cyclosporine. Transplantation Proceedings. 37(2). 864–866. 11 indexed citations
14.
Debruyne, Danièle, et al.. (1998). Benzodiazepines: Toxic Serum Concentrations in Positive Enzyme Immunoassay Responses. Journal of Analytical Toxicology. 22(7). 559–566. 5 indexed citations
15.
Debruyne, Danièle, D. Samba, Jean‐Michel Tartière, et al.. (1996). Bile and Blood Ratios of Cyclosporin and its Metabolites in Patients on Continuous Infusion During the First Three Weeks after Liver Transplantation. Clinical Drug Investigation. 12(2). 67–79. 2 indexed citations
16.
Debruyne, Danièle, et al.. (1994). Comparison of three advanced chromatographic techniques for cannabis identification.. PubMed. 46(2). 109–21. 17 indexed citations
17.
Barré, Louisa, Danièle Debruyne, Gilles Bonvento, et al.. (1992). Synthesis and regional rat brain distribution of [11C]MDL 72222: a 5HT3 receptor antagonist. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 43(4). 509–516. 13 indexed citations
18.
Debruyne, Danièle, et al.. (1990). Clinical Pharmacokinetics After Repeated Intrapleural Bupivacaine Administration. Clinical Pharmacokinetics. 18(3). 240–244. 10 indexed citations
19.
Debruyne, Danièle, et al.. (1990). Pharmacokinetics of Fluconazole in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis. Clinical Pharmacokinetics. 18(6). 491–498. 33 indexed citations
20.
Debruyne, Danièle, et al.. (1988). Pharmacocinétique de la pipéracilline en dialyse péritonéale continue ambulatoire.. Pathologie Biologie. 36(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kara L. Lynch Breakdown of academic impact, for papers by Hugo Kupferschmidt Breakdown of academic impact, for papers by Nicola Montanaro Breakdown of academic impact, for papers by Raffaele Giorgetti Breakdown of academic impact, for papers by Gordon McKay Breakdown of academic impact, for papers by Andrew A. Monte Breakdown of academic impact, for papers by Albert D. Fraser Breakdown of academic impact, for papers by S. Hill Breakdown of academic impact, for papers by S. Casey Laizure Breakdown of academic impact, for papers by Heather D. Langtry
Rankless by CCL
2026